Blood small extracellular vesicles derived miRNAs to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis

Abstract Background The differential diagnosis of pancreatic ductal adenocarcinoma (PDAC) from chronic pancreatitis (CP) is clinically challenging due to a lack of minimally invasive diagnosis methods. MicroRNAs (miRNAs) derived from small extracellular vesicles (EVs) in the blood have been reported...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Shiwei Guo, Hao Qin, Ke Liu, Huan Wang, Sijia Bai, Shiyi Liu, Zhuo Shao, Yanan Zhang, Bin Song, Xiaoya Xu, Jing Shen, Peng Zeng, Xiaohan Shi, Hao Chen, Suizhi Gao, Jiajia Xu, Yaqi Pan, Lei Xiong, Fugen Li, Dadong Zhang, Xiaodong Jiao, Gang Jin
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
Acceso en línea:https://doaj.org/article/13dcfc88aeee417aa47ae3e34fe7eeb4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:13dcfc88aeee417aa47ae3e34fe7eeb4
record_format dspace
spelling oai:doaj.org-article:13dcfc88aeee417aa47ae3e34fe7eeb42021-11-11T12:06:39ZBlood small extracellular vesicles derived miRNAs to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis2001-132610.1002/ctm2.520https://doaj.org/article/13dcfc88aeee417aa47ae3e34fe7eeb42021-09-01T00:00:00Zhttps://doi.org/10.1002/ctm2.520https://doaj.org/toc/2001-1326Abstract Background The differential diagnosis of pancreatic ductal adenocarcinoma (PDAC) from chronic pancreatitis (CP) is clinically challenging due to a lack of minimally invasive diagnosis methods. MicroRNAs (miRNAs) derived from small extracellular vesicles (EVs) in the blood have been reported as a promising diagnosis biomarker for various types of cancer. However, blood small EV miRNA signatures and their diagnostic value to differentiate between PDAC and CP remain to be determined. Methods In this study, 107 patients with PDAC or CP were recruited, and 90 patients were finally enrolled for a training cohort (n = 48) and test cohort (n = 42). Small RNA sequencing was used to assess the expression of blood small EV miRNAs in these patients. Results The linear model from the differentially expressed blood small EV miR‐95‐3p divided by miR‐26b‐5p showed an average sensitivity of 84.1% and an average specificity of 96.6% to identify PDAC from CP in the training cohort and the test cohort, respectively. When the model was combined with serum carbohydrate antigen 19‐9 (CA19‐9), the average sensitivity increased to 96.5%, and the average specificity remained at 96.4% of both cohorts, which demonstrated the best performance of all the published biomarkers for distinguishing between PDAC and CP. The causal analysis performed using the Bayesian network demonstrated that miR‐95‐3p was associated with a “consequence” of “cancer” and miR‐26b‐5p as a “cause” of “pancreatitis.” A subgroup analysis revealed that blood small EV miR‐335‐5p/miR‐340‐5p could predict metastases in both cohorts and was associated with an overall survival (p = 0.020). Conclusions This study indicated that blood small EV miR‐95‐3p/miR‐26b‐5p and its combination with serum levels of CA19‐9 could separate PDAC from CP, and miR‐335‐5p/miR‐340‐5p was identified to associate with PDAC metastasis and poor prognosis. These results suggested the potentiality of blood small EV miRNAs as differential diagnosis and metastases biomarkers of PDAC.Shiwei GuoHao QinKe LiuHuan WangSijia BaiShiyi LiuZhuo ShaoYanan ZhangBin SongXiaoya XuJing ShenPeng ZengXiaohan ShiHao ChenSuizhi GaoJiajia XuYaqi PanLei XiongFugen LiDadong ZhangXiaodong JiaoGang JinWileyarticlechronic pancreatitisdifferential diagnosispancreatic ductal adenocarcinomasmall extracellular vesicles miRNAsMedicine (General)R5-920ENClinical and Translational Medicine, Vol 11, Iss 9, Pp n/a-n/a (2021)
institution DOAJ
collection DOAJ
language EN
topic chronic pancreatitis
differential diagnosis
pancreatic ductal adenocarcinoma
small extracellular vesicles miRNAs
Medicine (General)
R5-920
spellingShingle chronic pancreatitis
differential diagnosis
pancreatic ductal adenocarcinoma
small extracellular vesicles miRNAs
Medicine (General)
R5-920
Shiwei Guo
Hao Qin
Ke Liu
Huan Wang
Sijia Bai
Shiyi Liu
Zhuo Shao
Yanan Zhang
Bin Song
Xiaoya Xu
Jing Shen
Peng Zeng
Xiaohan Shi
Hao Chen
Suizhi Gao
Jiajia Xu
Yaqi Pan
Lei Xiong
Fugen Li
Dadong Zhang
Xiaodong Jiao
Gang Jin
Blood small extracellular vesicles derived miRNAs to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis
description Abstract Background The differential diagnosis of pancreatic ductal adenocarcinoma (PDAC) from chronic pancreatitis (CP) is clinically challenging due to a lack of minimally invasive diagnosis methods. MicroRNAs (miRNAs) derived from small extracellular vesicles (EVs) in the blood have been reported as a promising diagnosis biomarker for various types of cancer. However, blood small EV miRNA signatures and their diagnostic value to differentiate between PDAC and CP remain to be determined. Methods In this study, 107 patients with PDAC or CP were recruited, and 90 patients were finally enrolled for a training cohort (n = 48) and test cohort (n = 42). Small RNA sequencing was used to assess the expression of blood small EV miRNAs in these patients. Results The linear model from the differentially expressed blood small EV miR‐95‐3p divided by miR‐26b‐5p showed an average sensitivity of 84.1% and an average specificity of 96.6% to identify PDAC from CP in the training cohort and the test cohort, respectively. When the model was combined with serum carbohydrate antigen 19‐9 (CA19‐9), the average sensitivity increased to 96.5%, and the average specificity remained at 96.4% of both cohorts, which demonstrated the best performance of all the published biomarkers for distinguishing between PDAC and CP. The causal analysis performed using the Bayesian network demonstrated that miR‐95‐3p was associated with a “consequence” of “cancer” and miR‐26b‐5p as a “cause” of “pancreatitis.” A subgroup analysis revealed that blood small EV miR‐335‐5p/miR‐340‐5p could predict metastases in both cohorts and was associated with an overall survival (p = 0.020). Conclusions This study indicated that blood small EV miR‐95‐3p/miR‐26b‐5p and its combination with serum levels of CA19‐9 could separate PDAC from CP, and miR‐335‐5p/miR‐340‐5p was identified to associate with PDAC metastasis and poor prognosis. These results suggested the potentiality of blood small EV miRNAs as differential diagnosis and metastases biomarkers of PDAC.
format article
author Shiwei Guo
Hao Qin
Ke Liu
Huan Wang
Sijia Bai
Shiyi Liu
Zhuo Shao
Yanan Zhang
Bin Song
Xiaoya Xu
Jing Shen
Peng Zeng
Xiaohan Shi
Hao Chen
Suizhi Gao
Jiajia Xu
Yaqi Pan
Lei Xiong
Fugen Li
Dadong Zhang
Xiaodong Jiao
Gang Jin
author_facet Shiwei Guo
Hao Qin
Ke Liu
Huan Wang
Sijia Bai
Shiyi Liu
Zhuo Shao
Yanan Zhang
Bin Song
Xiaoya Xu
Jing Shen
Peng Zeng
Xiaohan Shi
Hao Chen
Suizhi Gao
Jiajia Xu
Yaqi Pan
Lei Xiong
Fugen Li
Dadong Zhang
Xiaodong Jiao
Gang Jin
author_sort Shiwei Guo
title Blood small extracellular vesicles derived miRNAs to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis
title_short Blood small extracellular vesicles derived miRNAs to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis
title_full Blood small extracellular vesicles derived miRNAs to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis
title_fullStr Blood small extracellular vesicles derived miRNAs to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis
title_full_unstemmed Blood small extracellular vesicles derived miRNAs to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis
title_sort blood small extracellular vesicles derived mirnas to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis
publisher Wiley
publishDate 2021
url https://doaj.org/article/13dcfc88aeee417aa47ae3e34fe7eeb4
work_keys_str_mv AT shiweiguo bloodsmallextracellularvesiclesderivedmirnastodifferentiatepancreaticductaladenocarcinomafromchronicpancreatitis
AT haoqin bloodsmallextracellularvesiclesderivedmirnastodifferentiatepancreaticductaladenocarcinomafromchronicpancreatitis
AT keliu bloodsmallextracellularvesiclesderivedmirnastodifferentiatepancreaticductaladenocarcinomafromchronicpancreatitis
AT huanwang bloodsmallextracellularvesiclesderivedmirnastodifferentiatepancreaticductaladenocarcinomafromchronicpancreatitis
AT sijiabai bloodsmallextracellularvesiclesderivedmirnastodifferentiatepancreaticductaladenocarcinomafromchronicpancreatitis
AT shiyiliu bloodsmallextracellularvesiclesderivedmirnastodifferentiatepancreaticductaladenocarcinomafromchronicpancreatitis
AT zhuoshao bloodsmallextracellularvesiclesderivedmirnastodifferentiatepancreaticductaladenocarcinomafromchronicpancreatitis
AT yananzhang bloodsmallextracellularvesiclesderivedmirnastodifferentiatepancreaticductaladenocarcinomafromchronicpancreatitis
AT binsong bloodsmallextracellularvesiclesderivedmirnastodifferentiatepancreaticductaladenocarcinomafromchronicpancreatitis
AT xiaoyaxu bloodsmallextracellularvesiclesderivedmirnastodifferentiatepancreaticductaladenocarcinomafromchronicpancreatitis
AT jingshen bloodsmallextracellularvesiclesderivedmirnastodifferentiatepancreaticductaladenocarcinomafromchronicpancreatitis
AT pengzeng bloodsmallextracellularvesiclesderivedmirnastodifferentiatepancreaticductaladenocarcinomafromchronicpancreatitis
AT xiaohanshi bloodsmallextracellularvesiclesderivedmirnastodifferentiatepancreaticductaladenocarcinomafromchronicpancreatitis
AT haochen bloodsmallextracellularvesiclesderivedmirnastodifferentiatepancreaticductaladenocarcinomafromchronicpancreatitis
AT suizhigao bloodsmallextracellularvesiclesderivedmirnastodifferentiatepancreaticductaladenocarcinomafromchronicpancreatitis
AT jiajiaxu bloodsmallextracellularvesiclesderivedmirnastodifferentiatepancreaticductaladenocarcinomafromchronicpancreatitis
AT yaqipan bloodsmallextracellularvesiclesderivedmirnastodifferentiatepancreaticductaladenocarcinomafromchronicpancreatitis
AT leixiong bloodsmallextracellularvesiclesderivedmirnastodifferentiatepancreaticductaladenocarcinomafromchronicpancreatitis
AT fugenli bloodsmallextracellularvesiclesderivedmirnastodifferentiatepancreaticductaladenocarcinomafromchronicpancreatitis
AT dadongzhang bloodsmallextracellularvesiclesderivedmirnastodifferentiatepancreaticductaladenocarcinomafromchronicpancreatitis
AT xiaodongjiao bloodsmallextracellularvesiclesderivedmirnastodifferentiatepancreaticductaladenocarcinomafromchronicpancreatitis
AT gangjin bloodsmallextracellularvesiclesderivedmirnastodifferentiatepancreaticductaladenocarcinomafromchronicpancreatitis
_version_ 1718439010009874432